期刊文献+

鼻腔鼻窦鳞状细胞癌中PCNA和C-erbB-2的表达及临床意义研究 被引量:4

Study on the expression of PCNA and C-erb B-2 in nasal cavity paranasal sinus squamous cell carcinoma and it clinical significance
暂未订购
导出
摘要 目的探讨鼻腔鼻窦鳞状细胞癌中增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)和原癌基因蛋白质(oncogene protein,C-erb B-2)的表达情况及临床意义。方法利用免疫组织化学方法检测45例鼻腔鼻窦鳞癌的PCNA和C-erb B-2的表达情况,并选择15例正常鼻腔黏膜作为正常对照。结果各级鼻腔鼻窦鳞癌之中,PCNA和C-erb B-2均有表达,与正常对照鼻腔黏膜相比,差异均有统计学意义(P<0.05),且有随鳞癌分级升高表达不断增强的趋势。但在鳞癌中的表达,PCNA和C-erb B-2不存在显著的相关性。结论 PCNA和C-erb B-2的表达均能够反映出鼻腔鼻窦鳞状细胞癌的增殖活性,且其表达强度可以反映出鳞癌细胞的增殖活性高低。 Objective To explore the expression and clinical significance of proliferating cell nuclear antigen( PCNA) and oncogene protein( Cerb B-2) in the nasal cavity paranasal sinus squamous cell carcinoma. Method Expression of PCNA and C-erb B-2 were tested in 45 cases of the nasal cavity paranasal sinus squamous cell carcinoma by the immunohistochemical method,and 15 cases of normal nasal mucosa were selected as the normal control. Results All levels of sinonasal squamous cell carcinoma,PCNA and C-erb B-2 expressed in nasal mucosa,and compared with the normal control group,the differences were statistically significant( P〈0. 05),and with the increasing grade of squamous,cell carcinoma expression increased. But expression in squamous cell carcinoma,PCNA and C-erb B-2 had no significant correlation. Conclusion Expression of PCNA and C-erb B-2 can reflect the sinonasal squamous cell carcinoma proliferation activity,and the expression can reflect the proliferation activity of squamous cell carcinoma.
出处 《中国生化药物杂志》 CAS 2015年第1期94-96,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 鼻腔鼻窦鳞状细胞癌 增殖细胞核抗原 原癌基因蛋白质 sinus nasal squamous cell carcinoma proliferating cell nuclear antigen oncogene protein
  • 相关文献

参考文献14

二级参考文献120

共引文献62

同被引文献32

  • 1Krop I, Winer EP. Further progress in HER2-directed lherapy [J]. Lancet Oncol, 2012,13(1):2-3.
  • 2Shin C, Padhy LC, Murray M, et al. Transforming genes of carci- nomas and neuroblastomas introduced into mouse fibroblasts [ J ]. Nature, 1981, 290 ( 5803 ) :261 - 264.
  • 3Aumayr K, Soleiman A, Sahora K, et al.[IER2 gene amplification and protein expre.ssion in pan:reatic ductal adenoeareinomas[J ] Appl lmmunohistovhem Mol Morphol, 2014, 22(2) :146 - 152.
  • 4Kato H, Arao T, Matsumoto K, et al. Gene amplification of EGlrR, HER2, FGFR2 and MET in esophagus squamous cell car- cinoma[J]. Int J Oncol, 2013, 42(4):I151 -1158.
  • 5Ross JS, Wang K, Gay L,et al. A high tYequency of" activating extracellulm" domain ERBB2 ( HER2 ) mutation in miropapillary urothelial carcinonla[ J ]. Clin Cancer Res, 2014,20 ( 1 ) :68 -7.5.
  • 6Gomez-Mariin C, Plaza JC, Pazo-Cid R, et al. I.evel of tER2 gene amplifialim predicts response am] m'eral] survival in HER2-positive adva,eed gastric cancer treated with trastuzumab [J]. J Clin Oncol, 2013, 31 (35) :4445 -4452.
  • 7lwatsuki M, Toyoshima K, Watanabc M. et al. Frequency of HER2 expression of circulating tumor cells in patients with meta- static or recurrcnl gastrointestinal cancer[ J ]. Br J Cancer,2013, 109(11):3153-3161.
  • 8Bechmann T, Madscn .IS, Brandslund l, et at. Predicting brain metastases of breast cancer based on sertm S100B and sermn HER?. [J]. Oncol l,ett ,2013,6(5 ) : 1265 - 1270.
  • 9Xia Q,Zhu Z.Wang J,et al. Expression and association of ltFR2 with prognosis in early-stage (TI-T2NOMO) non-small cell hmg eancer[J]. Tumor Biol, 2012, 33(5) :1719 - 1725.
  • 10Wilkman TS, Hietanen JP, Mahnslrom M J, et al. hnmunohislo- chemical analysis of"/he oncoprotein -erbB-2 expression in oral benign and malignant lesions [ J ]. lnt J Oral Maxillolac Surg, 1998, 27(3) :209 -212.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部